152 related articles for article (PubMed ID: 14520432)
1. Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT.
Classen CF; Debatin KM; Friedrich W; Schulz AS
Bone Marrow Transplant; 2003 Oct; 32(8):843-6. PubMed ID: 14520432
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature.
Matthes-Martin S; Mann G; Peters C; Lion T; Fritsch G; Haas OA; Pötschger U; Gadner H
Bone Marrow Transplant; 2000 Aug; 26(4):377-82. PubMed ID: 10982283
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.
Vicente D; Lamparelli T; Gualandi F; Occhini D; Raiola AM; Ibatici A; Van Lint MT; Gobbi M; Miglino M; Clavio M; Risso M; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 2007 Aug; 40(4):349-54. PubMed ID: 17589537
[TBL] [Abstract][Full Text] [Related]
5. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
Chim CS; Lie AK; Liang R; Au WY; Kwong YL
Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
[TBL] [Abstract][Full Text] [Related]
7. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
8. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation.
Donadieu J; Stephan JL; Blanche S; Cavazzana-Calvo M; Baruchel A; Herbelin C; Benkerrou M; Thomas C; Girault D; Fischer A
Bone Marrow Transplant; 1994 Jun; 13(6):777-82. PubMed ID: 7920314
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation in a child with acute promyelocytic leukemia in second remission.
Quah TC; Yeoh AE; Sun L
Singapore Med J; 1997 Aug; 38(8):344-6. PubMed ID: 9364889
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
11. Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia.
Ashida T; Kawanishi K; Ariyama T; Hamasaki H; Maeda Y; Tsubaki K; Kanamaru A
Int J Hematol; 2000 Jun; 71(4):385-8. PubMed ID: 10905060
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of bone marrow transplantation to the treatment of children with leukemia].
Vossen JM; van Leeuwen EF; van 't Veer-Korthof ET; Slaper-Cortenbach CM; van den Berg H; Gerritsen EJ; Hermans J; Weening RS
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):73-82. PubMed ID: 3287686
[TBL] [Abstract][Full Text] [Related]
13. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
[TBL] [Abstract][Full Text] [Related]
14. European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT).
Mandelli F; Labopin M; Granena A; Iriondo A; Prentice G; Bacigalupo A; Sierra J; Meloni G; Frassoni F; Goldman J
Bone Marrow Transplant; 1994 Aug; 14(2):293-8. PubMed ID: 7994245
[TBL] [Abstract][Full Text] [Related]
15. Testicular relapse of AML during chronic graft-versus-host disease induced by donor leukocyte infusion.
Tringali S; Vasta S; Scimè R; Catania P; Cavallaro AM; Majolino I
Haematologica; 1996; 81(4):339-42. PubMed ID: 8870379
[TBL] [Abstract][Full Text] [Related]
16. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
18. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
[TBL] [Abstract][Full Text] [Related]
19. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.
Toze CL; Galal A; Barnett MJ; Shepherd JD; Conneally EA; Hogge DE; Nantel SH; Nevill TJ; Sutherland HJ; Connors JM; Voss NJ; Kiss TL; Messner HA; Lavoie JC; Forrest DL; Song KW; Smith CA; Lipton J
Bone Marrow Transplant; 2005 Nov; 36(9):825-30. PubMed ID: 16151430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
